John Glenn sold $900k of IRMD
CHIEF FINANCIAL OFFICER at IRADIMED CORP. 10,651 shares at an average of $84.51, traded Nov 10, 2025, filed Nov 12, 2025.
Score components
- +22RoleCFO
- +24Trade size$900k at market
- +20Share of holdings soldSold 81% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +11.6%, 3m +20.1%, 6m -0.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001253497-25-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | SOpen-market sale Common Stock | -10,651 | $84.51 | $900k | 2,500 | Nov 12, 2025 |
Related signals
Other insiders at IRADIMED CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | IRMDsell IRADIMED CORP | Monty K Allen director | $123k 1,419 shares | -7% | |
| 47Moderate | IRADIMED CORP | Hilda Frederique Scharen-Guivel director | $285k 3,000 shares | -35% | |
| 26Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $227k 2,500 shares | -0% | |
| 34Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $691k 7,500 shares | -0% | |
| 25Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $657k 7,500 shares | -0% | |
| 25Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $631k 7,500 shares | -0% | |
| 25Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $643k 7,500 shares | -0% | |
| 25Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $658k 7,500 shares | -0% | |
| 26Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $694k 7,500 shares | -0% | |
| 26Weak | IRADIMED CORP | Roger E. Susi CEO, President, Chairman | $697k 7,500 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.